SABBY MANAGEMENT, LLC
CIK: 1535610
Last 13F
Nov 13, 2026
Next 13F
Feb 15, 2027 · in 3mo
Options Notional
$2.33M
Holdings (14)
Q3 2026 13F, quarter ended Sep 30, 2026, filed Nov 13, 2026
- TOYO
TOYO CO LTD
$2.1M
482,175 sh31.35%-4.3% - PN
PN SMART ENERGY LTD
$737K
269,000 sh11.02%New - YXT
YXT COM GROUP HLDG LTD
$647K
286,085 sh9.66%New - ZVRA
ZEVRA THERAPEUTICS INC
$635K
57,850 sh9.49%New - CRVO
CERVOMED INC
$593K
199,678 sh8.86%-19.8% - APVO
APTEVO THERAPEUTICS INC
$423K
232,692 sh6.33%New - IWM
ISHARES
$278K
1,000 sh4.15%New - PAVS
PARANOVUS ENTERTNMNT TECH LTD
$261K
64,671 sh3.90%-14.3% - SNES
SENESTECH INC
$212K
313,132 sh3.17%+120.9% - CPHI
CHINA PHARMA HLDGS INC
$203K
308,360 sh3.03%New - CANF
CAN FITE BIOFARMA LTD
$187K
85,207 sh2.80%New - BCTXL
BRIACELL THERAPEUTICS CORP
$158K
136,365 sh2.36%-28.4% - SIDU
SIDUS SPACE INC
$155K
85,905 sh2.32%+98.0% - REVB
REVELATION BIOSCIENCES INC
$104K
126,915 sh1.55%-39.7%
| Security | Shares | Value | Change | Weight | Period |
|---|---|---|---|---|---|
TOYO TOYO CO LTD | 482,175 | $2.1M | -4.3% | 31.35% | Q3 2026 |
PN PN SMART ENERGY LTD | 269,000 | $737K | New | 11.02% | Q3 2026 |
YXT YXT COM GROUP HLDG LTD | 286,085 | $647K | New | 9.66% | Q3 2026 |
ZVRA ZEVRA THERAPEUTICS INC | 57,850 | $635K | New | 9.49% | Q3 2026 |
CRVO CERVOMED INC | 199,678 | $593K | -19.8% | 8.86% | Q3 2026 |
APVO APTEVO THERAPEUTICS INC | 232,692 | $423K | New | 6.33% | Q3 2026 |
IWM ISHARES | 1,000 | $278K | New | 4.15% | Q3 2026 |
PAVS PARANOVUS ENTERTNMNT TECH LTD | 64,671 | $261K | -14.3% | 3.90% | Q3 2026 |
SNES SENESTECH INC | 313,132 | $212K | +120.9% | 3.17% | Q3 2026 |
CPHI CHINA PHARMA HLDGS INC | 308,360 | $203K | New | 3.03% | Q3 2026 |
CANF CAN FITE BIOFARMA LTD | 85,207 | $187K | New | 2.80% | Q3 2026 |
BCTXL BRIACELL THERAPEUTICS CORP | 136,365 | $158K | -28.4% | 2.36% | Q3 2026 |
SIDU SIDUS SPACE INC | 85,905 | $155K | +98.0% | 2.32% | Q3 2026 |
REVB REVELATION BIOSCIENCES INC | 126,915 | $104K | -39.7% | 1.55% | Q3 2026 |
1-14 of 14 holdings
Derivatives (7)
PUT + CALL positions. Value is notional exposure of the underlying, not capital deployed.
- SIDUS SPACE INCPut
SIDUS SPACE INC
$968K
3,787 sh41.56%+30.4% - ZEVRA THERAPEUTICS INCPut
ZEVRA THERAPEUTICS INC
$376K
864 sh16.14%+102.3% - STATE STR SPDR S&P 500 ETFPut
STATE STR SPDR S&P 500 ETF
$333K
405 sh14.29%-44.1% - ISHARESPut
ISHARES
$281K
441 sh12.05%+0.0% - STATE STR SPDR S&P 500 ETFCall
STATE STR SPDR S&P 500 ETF
$205K
400 sh8.82%+95.1% - TOYO CO LTDCall
TOYO CO LTD
$108K
1,001 sh4.62%New - ISHARESCall
ISHARES
$58K
442 sh2.51%+0.0%
| Security | Type | Shares | Notional | Change | % of Book | Period |
|---|---|---|---|---|---|---|
SIDUS SPACE INC SIDUS SPACE INC | Put | 3,787 | $968K | +30.4% | 41.56% | Q3 2026 |
ZEVRA THERAPEUTICS INC ZEVRA THERAPEUTICS INC | Put | 864 | $376K | +102.3% | 16.14% | Q3 2026 |
STATE STR SPDR S&P 500 ETF STATE STR SPDR S&P 500 ETF | Put | 405 | $333K | -44.1% | 14.29% | Q3 2026 |
ISHARES ISHARES | Put | 441 | $281K | +0.0% | 12.05% | Q3 2026 |
STATE STR SPDR S&P 500 ETF STATE STR SPDR S&P 500 ETF | Call | 400 | $205K | +95.1% | 8.82% | Q3 2026 |
TOYO CO LTD TOYO CO LTD | Call | 1,001 | $108K | New | 4.62% | Q3 2026 |
ISHARES ISHARES | Call | 442 | $58K | +0.0% | 2.51% | Q3 2026 |
1-7 of 7 derivatives
Sector Allocation
SEC Filings
| Form | Description | Filed |
|---|---|---|
Sabby Management, LLC filed its most recent 13F holdings report, covering Q3 2026 (the quarter ended Sep 30, 2026), on Nov 13, 2026. Its largest reported positions by value are TOYO, PN, YXT, ZVRA and CRVO. A 13F lists US-listed stock and option positions, not total assets under management.
About SABBY MANAGEMENT, LLC
SABBY MANAGEMENT, LLC is an Investment Adviser that reports its US-listed stock and option positions to the SEC on Form 13F (CIK 1535610). Signal8 holds 21 13F filings from it. Its SEC filings list Delaware as its state of incorporation.
Its most recent 13F holdings report covers Q3 2026 (the quarter ended Sep 30, 2026) and was filed on Nov 13, 2026. That report lists 14 securities, not counting options, down from 16 in Q2 2026.
Its five largest reported positions, in order, are TOYO CO LTD (TOYO), PN SMART ENERGY LTD (PN), YXT COM GROUP HLDG LTD (YXT), ZEVRA THERAPEUTICS INC (ZVRA) and CERVOMED INC (CRVO). The next five are APTEVO THERAPEUTICS INC (APVO), ISHARES (IWM), PARANOVUS ENTERTNMNT TECH LTD (PAVS), SENESTECH INC (SNES) and CHINA PHARMA HLDGS INC (CPHI).
Recent 13F filings by SABBY MANAGEMENT, LLC
- Q3 2026: 13F-HR filed Nov 13, 2026, listing 14 securities.
- Q2 2026: 13F-HR filed Aug 14, 2026, listing 16 securities.
- Q1 2026: 13F-HR filed May 15, 2026, listing 22 securities.
- Q4 2025: 13F-HR filed Feb 17, 2026, listing 25 securities.
- Q3 2025: 13F-HR filed Nov 14, 2025, listing 29 securities.
- Q2 2025: 13F-HR filed Aug 14, 2025, listing 33 securities.